Literature DB >> 33311629

US authorization of first COVID vaccine marks new phase in safety monitoring.

Heidi Ledford.   

Abstract

Entities:  

Keywords:  Infection; Medical research; SARS-CoV-2; Vaccines

Mesh：

Substances：

Year:  2020        PMID： 33311629     DOI： 10.1038/d41586-020-03542-4

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  1 in total

1.  Respiratory Syncytial Virus Vaccination during Pregnancy and Effects in Infants.

Authors:  Shabir A Madhi; Fernando P Polack; Pedro A Piedra; Flor M Munoz; Adrian A Trenholme; Eric A F Simões; Geeta K Swamy; Sapeckshita Agrawal; Khatija Ahmed; Allison August; Abdullah H Baqui; Anna Calvert; Janice Chen; Iksung Cho; Mark F Cotton; Clare L Cutland; Janet A Englund; Amy Fix; Bernard Gonik; Laura Hammitt; Paul T Heath; Joanne N de Jesus; Christine E Jones; Asma Khalil; David W Kimberlin; Romina Libster; Conrado J Llapur; Marilla Lucero; Gonzalo Pérez Marc; Helen S Marshall; Masebole S Masenya; Federico Martinón-Torres; Jennifer K Meece; Terry M Nolan; Ayman Osman; Kirsten P Perrett; Joyce S Plested; Peter C Richmond; Matthew D Snape; Julie H Shakib; Vivek Shinde; Tanya Stoney; D Nigel Thomas; Alan T Tita; Michael W Varner; Manu Vatish; Keith Vrbicky; Judy Wen; Khalequ Zaman; Heather J Zar; Gregory M Glenn; Louis F Fries
Journal:  N Engl J Med       Date:  2020-07-30       Impact factor: 91.245
  1 in total
  16 in total

1.  Antibody response after a booster dose of BNT162B2mRNA and inactivated COVID-19 vaccine.

Authors:  Metin Yigit; Aslinur Ozkaya-Parlakay; Yasemin Cosgun; Yunus Emre Ince; Furkan Kalayci; Naci Yilmaz; Emrah Senel
Journal:  J Clin Virol Plus       Date:  2022-06-30

Review 2.  COVID-19: vaccination problems.

Authors:  Harald Brüssow
Journal:  Environ Microbiol       Date:  2021-05-14       Impact factor: 5.476

3.  Guillain-Barre syndrome should be monitored upon mass vaccination against SARS-CoV-2.

Authors:  Char Leung
Journal:  Hum Vaccin Immunother       Date:  2021-05-25       Impact factor: 4.526

Review 4.  A Review on SARS-CoV-2-Induced Neuroinflammation, Neurodevelopmental Complications, and Recent Updates on the Vaccine Development.

Authors:  Medha Karnik; Narasimha M Beeraka; Chinnappa A Uthaiah; Suma M Nataraj; Anjali Devi S Bettadapura; Gjumrakch Aliev; SubbaRao V Madhunapantula
Journal:  Mol Neurobiol       Date:  2021-06-05       Impact factor: 5.590

Review 5.  Review of Covid-19 vaccine clinical trials - A puzzle with missing pieces.

Authors:  Hang Fai Kwok
Journal:  Int J Biol Sci       Date:  2021-04-10       Impact factor: 6.580

Review 6.  Clinical data to be used as a foundation to combat Covid-19 vaccine hesitancy.

Authors:  Robert G Smith
Journal:  J Interprof Educ Pract       Date:  2021-12-11

7.  Excess mortality in Belarus during the COVID-19 pandemic as the case study of a country with limited non-pharmaceutical interventions and limited reporting.

Authors:  Alexander Kirpich; Aleksandr Shishkin; Thomas A Weppelmann; Alexander Perez Tchernov; Pavel Skums; Yuriy Gankin
Journal:  Sci Rep       Date:  2022-03-31       Impact factor: 4.379

Review 8.  Self-assembled mRNA vaccines.

Authors:  Jeonghwan Kim; Yulia Eygeris; Mohit Gupta; Gaurav Sahay
Journal:  Adv Drug Deliv Rev       Date:  2021-01-02       Impact factor: 17.873

Review 9.  Stroke Associated with COVID-19 Vaccines.

Authors:  Maryam Kakovan; Samaneh Ghorbani Shirkouhi; Mojtaba Zarei; Sasan Andalib
Journal:  J Stroke Cerebrovasc Dis       Date:  2022-03-04       Impact factor: 2.677

10.  Transmission dynamics and forecasts of the COVID-19 pandemic in Mexico, March-December 2020.

Authors:  Amna Tariq; Juan M Banda; Pavel Skums; Sushma Dahal; Carlos Castillo-Garsow; Baltazar Espinoza; Noel G Brizuela; Roberto A Saenz; Alexander Kirpich; Ruiyan Luo; Anuj Srivastava; Humberto Gutierrez; Nestor Garcia Chan; Ana I Bento; Maria-Eugenia Jimenez-Corona; Gerardo Chowell
Journal:  PLoS One       Date:  2021-07-21       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.